×
Xu, Jiahua

Dating death: an empirical comparison of medical underwriters in the U.S. life settlements market. (English) Zbl 1437.91401

N. Am. Actuar. J. 24, No. 1, 36-56 (2020).
Summary: The value of a life settlement investment, manifested through a traded life insurance policy, is highly dependent on the insured’s life expectancy (LE). LE estimation in life settlements relies heavily on medical underwriting. Employing different evaluation processes, underwriters rarely agree on LE estimates, leading to valuation disparities. We use the natural logarithm of the implied mortality multiplier \((\ln k)\) to compare the underwriting results of the four major U.S. medical underwriters (ITM, AVS, Fasano, and LSI). \(\ln k\) is normalized in terms of gender, age, and smoking status, and is therefore a more suitable indicator than LE estimates for high-level comparisons, especially when the compared groups have a heterogeneous make-up. Based on the analysis of life settlement samples from 2011 to 2016, we trace patterns of underwriters’ \(\ln k\) in both secondary and tertiary markets of life settlements, and investigate systematic differences in their estimation. Our results show that an underwriter can, relative to peers, act more conservatively (issuing longer LE estimates) for one cohort while more aggressively (issuing shorter LE estimates) for another. We also detect signs of intermediaries’ cherry-picking behavior and discuss additional theories that shed light on the convoluted LE landscape.

Cited in 2 Documents

MSC:

91G05 Actuarial mathematics

Keywords:

life settlement investment; life insurance; life expectancy estimation
PDF BibTeX XML Cite
\textit{J. Xu}, N. Am. Actuar. J. 24, No. 1, 36--56 (2020; Zbl 1437.91401)
Full Text: DOI
  • logo of hbz
  • logo of WorldCat

References:

[1] . 2010. 21st Services’ 98.1
[2] . 2011. 21st services’ actual-to-expected is 94.7
[3] . 2013. Frequently asked questions regarding 2013 underwriting adjustments.
[4] . 2016. Annual transaction volume for secondary and tertiary market & outstanding total US life settlement volume.
[5] . 2013. Life settlements mortality. Actuarial Standard of Practice.
[6] Best., A. M.2016. Life settlement securitization. A.M. Best Criteria Procedure.
[7] An, J., EEA Life Settlements Fund—An independent case study (2014), Warwick Business School
[8] Aspinwall, J., Chaplin, G., and Venn, M.. 2009. The parties involved in a life settlement transaction. Life Settlements and Longevity Structures: Pricing and Risk Management15-18.
[9] 2013. Assured fund shareholder letter.
[10] Bahna-Nolan, M., Mortality table development update 2014 VBT/CSO, NAIC Life Actuarial Task Force Meeting (2014)
[11] Bauer, D.; Fasano, M. V.; Russ, J.; Zhu., N., Evaluating life expectancy evaluations, North American Actuarial Journal, 22, 2, 198-209 (2018) · Zbl 1393.91098
[12] Bauer, D.; Gao, J.; Moenig, T.; Ulm, E. R.; Zhu., N., Policyholder exercise behavior in life insurance: The state of affairs, North American Actuarial Journal, 21, 4, 485-501 (2017) · Zbl 1414.91161
[13] Bauer, D.; Russ, J.; Zhu, N., Adverse selection in insurance markets: Evidence from the life settlement market, Proceedings of the NBER Insurance Workshop 2014 (2014)
[14] Blake, D.; Harrison., D., And death shall have no dominion: Life settlements and the ethic of profiting from mortality (2008)
[15] 2010. Re: actual/expected analysis.
[16] Braun, A.; Affolter, S.; Schmeiser., H., Life settlement funds: Current valuation practices and areas for improvement, Risk Management and Insurance Review, 19, 2, 173-195 (2015)
[17] Braun, A., Cohen, L. H., Malloy, C. J. and Xu., J.2018a. Introduction to life settlements. Harvard Business School Background Note 218-127.
[18] Braun, A., Cohen, L. H., Malloy, C. J., Xu, J.. 2018b. Ashar Group: Brokers and co-opetition in the life settlement industry. Harvard Business School Case 218-109.
[19] Braun, A.; Gatzert, N.; Schmeiser., H., Performance and risks of open-end life settlement funds, Journal of Risk and Insurance, 79, 1, 193-230 (2012)
[20] Cohen, L. H. 2013. Seeking alpha in the afterlife: CMG Life Services and the life settlement industry. Harvard Business School Case 214-011.
[21] Life settlement market review, LISA Institutional Investor Life Settlement Conference. New York, NY. (2017)
[22] Cook, D.; Ezell., G., Life settlement characteristics and mortality experience for two providers. Milliman Research Report (2008)
[23] Cowley, A.; Cummins., J. D., Securitization of life insurance assets and liabilities, Journal of Risk and Insurance, 72, 2, 193-226 (2005)
[24] Doherty, N. A.; Singer, H. J., The benefits of a secondary market for life insurance policies, Real Property, Probate and Trust Journal, 38, 3, 449-478 (2003)
[25] . 2016. EEA fund facts at December 2016.
[26] Emery, R. 2011. Assured Fund imposes exit restrictions on investors. Money Observer.
[27] . 2009. EMSI revises life expectancy mortality tables in response to 2008 VBT.
[28] Fasano, M. 2013. Underwriting methodologies.
[29] 2016. Life expectancy providers; registration required; Denial, suspension, revocation.
[30] Gottlieb, D., and Smetters., K.2016. Lapse-based insurance.
[31] Granieri, V. J.; Heck., G. P., Survival characteristics of three senior populations, with a focus on life settlements (2014)
[32] Hendel, I.; Lizzeri., A., The role of commitment in dynamic contracts: Evidence from life insurance, Quarterly Journal of Economics, 118, 1, 299-327 (2003) · Zbl 1057.91046
[33] Horowitz, D., Life expectancy dispute hurts market, key players Say, Life Settlements Report, IV, 19, 8-10 (2010)
[34] Horowitz, D., Wells Fargo issues foreclosure notice against Lifetrade Fund Sep 2012, Life Settlements Report, VI, 15, 8-9 (2012)
[35] Horowitz, D., Settlement transactions continued to drop in 2012, market survey shows. Life Settlements Report (2013)
[36] Horowitz, D. 2013b. Texas rejects ILMA’s request to eliminate life expectancy provider licensing.
[37] Horowitz, D., 2013 Saw end of market’s decline. Life Settlements Report, Special Report (2014)
[38] Horowitz, D., Life settlement transactions plummet volume. Life Settlements Report, Special Report (2015)
[39] Horowitz, D., AVS plans to increase prices for life expectancy reports in January (2016)
[40] Horowitz, D., Market volume increases 32
[41] 2016. Data subscription & dictionary.
[42] Januário, A. V.; Naik., N. Y., Testing Adverse Selection in Life Settlements: The Secondary Market for Life Insurance Policies (2014)
[43] 2016. Re: actual to expected analyses: 2008 Through 2015.
[44] 2011. Life Expectancy Providers best practices.
[45] . 2016. Life settlement industry timeline.
[46] . 2017. LSI underwriting process.
[47] Olivieri, A.; Pitacco, E., Introduction to Insurance Mathematics: Technical and Financial Features of R’sk Transfers, Life insurance: Modeling the lifetime, 157-216 (2015)
[48] Rivoli, D. 2011. Creditors slam financing plan in New Stream’s Ch. 11. Law360.
[49] . 2013. Performance report for ClaridenLeu for the K1 life settlement note.
[50] Robins, W. 2013. ARM Life Settlement Fund appoints liquidators. New Model Adviser—Citywire.
[51] Roland, R., Life settlement tertiary market dynamics, . In: Fasano 13th Annual Longevity Conference (2016)
[52] Russ, J.; Schocller, F.; Witt, M., SCOPE Jahrbuch Geschlossene Fonds, Wie gut sind die Lebenserwartungsgutachten bei US-Policenfonds, 373-379 (2005)
[53] Seitel, C. L., Evolution of the life settlement industry: A provider’s reflection on trends and developments, Journal of Structured Finance, 14, 2, 55-58 (2008)
[54] Sheridan, M. 2019. Evolution of the Life Settlements Market. In The STOLI Worm: A Practitioner’s Guide to Managing Life Settlements and Micro Longevity Risk.
[55] Siegert, P. 2010. Evolution of life expectancies in the life insurance secondary market… Current trends and new developments. Life Insurance Settlement Series VI.
[56] Stone, C. A.; Zissu., A., Securitization of senior life settlements: Managing extension risk, Journal of Derivatives, 13, 3, 66-72 (2006)
[57] 2016. License application for a life settlement provider or broker. Licensing of Life Settlement Providers, Brokers, and Life Agents Acting as Life Settlement Brokers.
[58] Tracer, Z., AIG has \(832 million cost on death bets as hedge funds gain (2014), Bloomber\)
[59] Trinkwon, D. 2017. EEA Investors’ Group update.
[60] Whitney, Craig R. (1997)
[61] Xu, J.; Hoesch., A., Predicting longevity: An analysis of potential alternatives to life expectancy reports, Journal of Retirement, 5, 4, 9-24 (2018)
[62] Zhu, N.; Bauer., D., Coherent pricing of life settlements under asymmetric information, Journal of Risk and Insurance, 80, 3, 827-851 (2013)
This reference list is based on information provided by the publisher or from digital mathematics libraries. Its items are heuristically matched to zbMATH identifiers and may contain data conversion errors. It attempts to reflect the references listed in the original paper as accurately as possible without claiming the completeness or perfect precision of the matching.